Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangyin Square Garden Pharmaceutical, also known as Jiangyin Fangyuan Pharmaceutical, is a Chinese pharmaceutical company established in 1994 and headquartered in Jiangyin, Jiangsu Province. The company specializes in the development, production, and marketing of chemical generic drugs and traditional Chinese medicine (TCM) preparations. Its product portfolio covers several major therapeutic areas, including cardiovascular health, gastroenterology, and respiratory medicine, with key products such as Omeprazole and Compound Danshen formulations. Operating from GMP-certified facilities, the company integrates research and development with large-scale manufacturing to serve the domestic Chinese healthcare market. It is recognized as a high-tech enterprise in Jiangsu Province and maintains a strong presence in the regional pharmaceutical industry under the Fangyuan brand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangyin Square Garden Pharmaceutical.